Cambridge, MA, United States of America

Junping Zhao



 

Average Co-Inventor Count = 8.4

ph-index = 4

Forward Citations = 35(Granted Patents)


Location History:

  • Waltham, MA (US) (2016 - 2020)
  • Cambridge, MA (US) (2016 - 2020)
  • Arlington, MA (US) (2019 - 2021)

Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Junping Zhao: Innovator in Biomedicine

Introduction

Junping Zhao is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of biomedicine. With a total of 7 patents, he has focused on developing innovative solutions for various health-related issues.

Latest Patents

Zhao's latest patents include groundbreaking work on organic compositions to treat APOC3-related diseases. This patent addresses conditions such as hypertriglyceridemia, abnormal lipid metabolism, and cardiovascular diseases by utilizing RNAi agents targeting APOC3. Another notable patent involves lipids and lipid compositions designed for the effective delivery of active agents to cells and tissues, showcasing his commitment to advancing therapeutic methods.

Career Highlights

Throughout his career, Junping Zhao has worked with leading companies in the pharmaceutical industry, including Novartis AG and Arrowhead Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in medical treatments.

Collaborations

Zhao has collaborated with notable professionals in his field, including Jeremy Lee Baryza and Keith Bowman. These partnerships have further enhanced his research and development efforts.

Conclusion

Junping Zhao's innovative work in biomedicine continues to impact the treatment of various diseases. His patents reflect a dedication to improving health outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…